(Q45885660)

17 December 2017

title

Eradication of hepatocellular carcinoma xenografts by radiolabelled, lipiodol-inducible gene therapy (English)

1 reference

17 December 2017

0 references

1 reference

9

1 reference

17 December 2017

author name string

Kawashita Y

1

1 reference

17 December 2017

Ohtsuru A

2

1 reference

17 December 2017

Miki F

3

1 reference

17 December 2017

Kuroda H

4

1 reference

17 December 2017

Morishita M

5

1 reference

17 December 2017

Kaneda Y

6

1 reference

17 December 2017

Hatsushiba K

7

1 reference

17 December 2017

Kanematsu T

8

1 reference

17 December 2017

publication date

1 November 2005

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

22

1 reference

17 December 2017

page(s)

1633-1639

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302531

exact match

0 references

cites work

Provocative gene therapy strategy for the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Regression of established macroscopic liver metastases after in situ transduction of a suicide gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Development of anti-tumor immunity following thymidine kinase-mediated killing of experimental brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Gene therapy for brain tumors: regression of experimental gliomas by adenovirus-mediated gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Expression of alpha-fetoprotein and albumin genes in human hepatocellular carcinomas: limitations in the application of the genes for targeting human hepatocellular carcinoma in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Spatial and temporal control of gene therapy using ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Regression of hepatocellular carcinoma in vitro and in vivo by radiosensitizing suicide gene therapy under the inducible and spatial control of radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Induction of the suicide HSV-TK gene by activation of the Egr-1 promoter with radioisotopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Hepatic artery injection of I-131-labeled lipiodol. Part II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Intra-arterial iodine 131-labeled lipiodol as adjuvant therapy after curative liver resection for hepatocellular carcinoma: a phase 2 clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Interventional nuclear medicine in hepatocellular carcinoma and other tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Adjuvant intra-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Impaired prostate tumorigenesis in Egr1-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Persistent gene expression in rat liver in vivo by repetitive transfections using HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

Serum alpha-fetoprotein levels in human disease: perspective from a highly specific monoclonal radioimmunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Preoperative treatment of hepatocellular carcinoma with intra-arterial injection of 131I-labelled lipiodol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Adjuvant intra-arterial injection of iodine-131-labeled lipiodol after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Low dose ionizing radiation-induced activation of connexin 43 expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Studies on anticancer treatment with an oily anticancer drug injected into the ligated feeding hepatic artery for liver cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Selective effects of lipiodolized antitumor agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Evaluation of intrahepatic I-131 ethiodol on a patient with hepatocellular carcinoma. Therapeutic feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Transarterial internal radiation therapy with I-131 Lipiodol for multifocal hepatocellular carcinoma: immediate and long-term results

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Internal radiation therapy for hepatocellular carcinoma. Results of a french multicenter phase II trial of transarterial injection of iodine 131-labeled lipiodol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Internal radiation therapy for patients with primary or metastatic hepatic cancer: a review

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302531

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302531

1 reference

17 December 2017

Dimensions Publication ID

1019238911

0 references

1 reference

17 December 2017